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Abstract 
BACKGROUND:  Evaluating the antibiotic susceptibility and resistance genes is essential in the clinical 
management of bloodstream infections (BSIs). Nevertheless, there are still limited studies in Northern Vietnam.  
AIM: This study aimed to determine the antibiotic resistance profile and methicillin-resistant encoding genes of 
Staphylococcus aureus (S. aureus) causing BSIs in Northern Vietnam.  
METHODS: The cross-sectional study was done from December 2012 to June 2014 in two tertiary hospitals in 
Northern Vietnam. Tests performed at the lab of the hospital.  
RESULTS:  In 43 S. aureus strains isolating, 53.5 % were MRSA. Distribution of gene for overall, MRSA, and 
MSSA strains were following: mecA gene (58.1 %; 95.7%, and 15%), femA gene (48.8%, 47.8%, and 50%), femB 
gene (88.4%, 82.6%, and 95%). Antibiotic resistance was highest in penicillin (100%), followed by erythromycin 
(65.1%) and clindamycin (60.5%). Several antibiotics were susceptible (100%), including vancomycin, tigecycline, 
linezolid, quinupristin/dalfopristin. Quinolone group was highly sensitive, include ciprofloxacin (83.7%), 
levofloxacin (86%) and moxifloxacin (86%). 
CONCLUSION: In S. aureus causing BSIs, antibiotic resistance was higher in penicillin, erythromycin, and 
clindamycin. All strains were utterly susceptible to vancomycin, tigecycline, linezolid, quinupristin/dalfopristin.  
 
 
 
 
Introduction 
 
 Bloodstream infections (BSIs) became a 
significant concern with increasing in incidence [1]. 
Understanding the aetiology of BSI was essential for 
management. In Asian countries, S. aureus was one 
of the leading causes of bloodstream infections [2], 
and its incidence was increasing worldwide [3], [4]. It 
was responsible for many severe clinical conditions, 
especially in bloodstream infections [5] with rates of 
mortality was 50% [6]. With subtype of methicillin-
resistant staphylococcus aureus (MRSA), the 
prevalence and mortality were higher than methicillin-
susceptible staphylococcus aureus (MSSA) [7]. The 
burden of MRSA disease was quantifiable and 
substantial [8]. In European, Cassini et al. used 
population-level model estimating that MRSA caused 
148 thousand infections and 32.6 thousand BSIs in 
2015 [9]. In Asia, among patients with community-
associated S. aureus infections, MRSA accounted for 
25.5% [10]. Under increasing in prevalence, 
increasing resistance also reported, especially MRSA 
[11]. It caused many clinical conditions with poor 
outcomes [12]. Patients with MRSA in BSIs had a 
worse prognosis because of partially effect on correct 
empirical treatment [13]. It became a global concern 
[14] with the increasing burden of cost [15] and the 
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resistance to all classes of antibiotics [16]. Therefore, 
evaluation of the antibiotic susceptibility of bacteria is 
essential to decide what types of medicines and what 
appropriate doses that are improving treatment 
efficiency and minimising the antibiotic resistance 
rate.  
 In Vietnam, MRSA accounted for 67.4% of S. 
aureus healthcare-associated infections [10]. The 
study of causes in BSIs patients in Northern Vietnam 
showed 37% of methicillin-resistance among S. 
aureus [17], but there are still limited studies in 
Northern Vietnam. Thus, our research aims is to 
determine the antibiotic resistance profile and the 
prevalence of methicillin-resistant encoding genes in 
S. aureus, causing bloodstream infections in Northern 
Vietnam. 
 
 
Materials and Methods 
 
 The cross-sectional study was done from 
12/2012 to 6/2014 in the National Hospital of Tropical 
Diseases and 103 Military Hospital. Isolating blood 
samples from septicemia patients in two hospitals, 43 
S. aureus strains were identified at the labs of those 
hospitals. The information of patients collected on the 
same forms.  
 Antimicrobial susceptibility assessed 
through MIC test by VITEK
®
2 Compact (BioMérieux, 
France and provided by DEKA Limited Liability 
Company) standardised by CLSI [18]. Antibiotics which 
have been used arewere (with number coding – 
abbreviation for Figure 3): penicillin (1-PEN), 
gentamycin (2-GM), ciprofloxacin (3-CIP), levofloxacin 
(4-LVX), moxifloxacin (5- MXF), tetracycline (6-TE), 
erythromycin (7-ERY), clindamycin (8-CM), 
trimethoprim/sulfamethoxazole (9-SXT), vancomycin 
(10-VAN), rifampin (11-RIF), quinupristin/dalfopristin 
(12-QD), linezolid (13-LZD), oxacillin (14-OXA), 
tigecycline (15-TGE). 
 Using QIAamp DNA Mini Kit (USA) for DNA 
extraction (including isolation and quantification), we 
performed the experimental procedure according to 
manufacturer’s instruction. PCR amplification 
performed in PCR master mix (Invitrogen – USA) that 
consisted of 200 µM of each dNTPs (dATP, dCTP, 
dGTP, dTTP), 100 pM primers, 1 U Taq DNA 
polymerase, 10 mM Tris-HCl, 1.5 mM MgCl2 and 10 µl 
DNA template. Specific primers for mecA, femA, and 
femB genes showed in table 1. The experiments were 
performed using the protocol with 25 cycles that each 
of them consisted of 3 steps including denaturing 
(94
0
C for 1 minute), priming (57
0
C for 1 minute), 
synthesising of sequence (72
0
C for 1 minute). PCR 
products were performed electrophoresis, imaged 
routinely and sequenced. The sequence of PCR 
products was compared with the original gene’s 
sequence on GenBank to confirm mecA, femA, and 
femB genes. 
Table 1: Specific primers for mecA gene 
Target 
gene 
Primer  Nucleotide sequence (5’ – 3’) 
Size 
(bp) 
Location 
mecA 
Mec-A1 5’ – AAA ATC GAT GGT AAA GGT TGG C – 3’  
533 
1282-1303 
Mec-A2 5’ – AGT TCT GCA GTA CCG GAT TTG C – 3’ 1739-1814 
femA 
Fem-A1 5’ – AGA CAA ATA GGA GTA ATG AT – 3’ 
509 
595-614 
Fem-A2 5’ – AAA TCT AAC ACT GAG TGA TA – 3’ 1084-1103 
femB 
Fem-B1 5’ – TTA CAG AGT TAA CTG TTA CC – 3’ 
651 
1904-1923 
Fem-B2 5’ – ATA CAA ATC CAG CAC GCT CT – 3’ 2535-2554 
 
 
 Ethical considerations 
 The Ethics Committee of the National Hospital 
of Tropical Diseases and Military Hospital 103 
approved the protocol of the study. The study was in 
line with the Declaration of Helsinki. Written informed 
consent has been signed by all participants after full 
explanation. After that, the blood samples were 
collected. 
 
 Statistical Analysis  
 The statistical analysis was conducted using 
the R language. Graphics also were performed by the 
R language. In this study, the analysis of such 
enormous volumes of information in the acquisition of 
data from 43 strains, each strain companion with 
genes (mecA, femA, and femB) and 15 antibiotics with 
3 levels of resistance (susceptible, intermediate, 
resistance). For this reason, we used R language to 
analyse. 
 
 
Results 
 
 Characteristics of the patient in this study 
showed in Table 2. 
Table 2: Characteristics of patients 
Characteristics Number (Percentage) 
Age (subgroup) 
16-19 
20-29 
30-39 
40-49 
50-59 
≥ 60 
 
5 (11.63) 
5 (11.63) 
11 (25.58) 
7 (16.28) 
9 (20.93) 
6 (13.95) 
Gender 
Male 
Female 
 
40 (93.02 %) 
3 (6.98 %) 
History of the medical conditions 
Cirrhosis 
Self-report alcoholism  
Spinal cord injury 
Diabetes 
Hypertension 
Hepatitis 
Chronic arthritis 
Urinary tract stone 
Heart failure 
Deep vein thrombosis 
No 
 
4 (9.3) 
4 (9.3) 
3 (6.98) 
2 (4.65) 
2 (4.65) 
2 (4.65) 
2 (4.65) 
1 (2.33) 
1 (2.33) 
1 (2.33) 
21 (48.83) 
 Time to hospitalization 
< 5 
5-14 
>14 
 
17 (39.53) 
21 (48.84) 
5 (11.63) 
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 Among 43 S. aureus strains isolated 
analysed, 23 S. aureus strains were MRSA strains 
(53.5 %), and 20 S. aureus strains were MSSA strains 
(46.5%). Detail information of showed in Table 3.  
Table 3: Methicillin-resistant S. aureus and methicillin-resistant 
encoding genes 
Result Number of strains (n = 43) 
Percentage (%) 
MRSA 23 (53.49%) 
MSSA 20 (46.51%) 
mecA 
 
25 (58.13%) 
 
femA 
 
21 (48.84%) 
 
femB 
 
38 (88.37%) 
mecA + femA 11 (25.58%) 
mecA + femB 23 (53.84%) 
mecA + femA + femB 10 (23.25%) 
 
 And among that, 58.1 % strains were 
identified as producing mecA, and 22 of 23 MRSA 
strains (95.7%) proved to be having mecA gene when 
15% strains in the MSSA group possessed this gene. 
The prevalence of femB gene of overall strains, 
MRSA, and MSSA was 88.4%, 82.6%, and 95%, 
respectively. The prevalence of femA gene of whole 
strains, MRSA, and MSSA was 48.8%, 47.8%, and 
50%, respectively. More information showed in Table 
4. 
Table 4: Encoding genes of methicillin-resistant in S. Aureus 
 
Gene 
MRSA 
(n = 23) 
MSSA 
(n = 20) 
Positive (+) Negative (-) Positive (+) Negative (-) 
n (%) n (%) n (%) n (%) 
mecA 22 95.65 1 4.34 3 15 17 85 
femA 11 47.83 12 52.17 10 50 10 50 
femB 19 82.6 4 17.4 19 95 1 5 
mecA + femA 10 43.47 13 56.53 1 5 19 95 
mecA + femB 17 73.91 6 26.09 6 30 14 70 
mecA + femA + femB 9 39.13 14 60.87 1 5 19 95 
 
  
 Figure 1 showed the highest prevalence of 
resistance to penicillin (PEN -100%), followed by 
erythromycin (ERY - 65.1%) and clindamycin (CM - 
60.5%).  
 
Figure 1: Antibiotic resistant profile  
 
 While Figure 2 showed highly active 
antibiotics in quinolone group, include ciprofloxacin 
(CIP - 83.7% of isolates), levofloxacin (LVX - 86.1% of 
isolates) and moxifloxacin (MXF - 86.1% of isolates). 
Several antibiotics were susceptible (100%), include 
vancomycin, tigecycline, linezolid, quinupristin/ 
dalfopristin.  
 
Figure 2: Antibiotic sensitivity profile  
 
 The level of resistance (MIC) in MRSA group 
to clindamycin, erythromycin, tetracycline, 
levofloxacin, ciprofloxacin, moxifloxacin was higher 
than MSSA group. In each antibiotic, detail 
information of genes showed. Figure 3 showed that 
the distribution of three femA, femB, and mecA genes 
is equivalent to 15 antibiotics.  
 
Figure 3: Distribution the antibiotic resistance level with genes. 
Antibiotic gene: 1.FemA; 2.FemB; 3.MecA. Antibiotic resistance 
level: From 1 to 3 are R, S, I, respectively; Antibiotic: From 1 to 15 
is the ordinal number of 15 antibiotics  
 
 
 
 The rate of sensitivity also accounts for the 
majority of ciprofloxacin, levofloxacin, moxifloxacin, 
linezolid, quinupristin/ dalfopristin, rifampin, 
tigecycline, vancomycin distributed in all three genes 
but most in the femB gene. The intermediate 
response is concentrated in moxifloxacin and rifampin 
antibiotics. Antibiotic resistance focused on antibiotics 
clindamycin, erythromycin, oxacillin, penicillin, and 
tetracycline. Figure 3 supported figures 1 and 2 to 
visualise the association between the gene and 
antibiotic resistance. 
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 Table 5 clarified the detail of antibiotic 
resistance with S. aureus. While MRSA strains were 
highly resistant to penicillin, erythromycin, 
clindamycin, and tetracycline with the rate following: 
100%, 82.6%, 87%, 73.9%, respectively, MSSA 
strains showed a lower prevalence of resistance to 
these agents with the rate following: 20%, 9%, 6%, 
3%, respectively. Both groups were susceptible to 
vancomycin, tigecycline, linezolid, quinupristin/ 
dalfopristine at the rate of 100%. 
Table 5: The antibiotic resistance profile of S. Aureus 
Antimicrobial 
agents 
MRSA MSSA 
S 
(%) 
I 
(%) 
R 
(%) 
S 
(%) 
I 
(%) 
R 
(%) 
Penicillin    23 (100)   20 (100) 
Erythromycin  4 (17.39)  19 (82.61) 11 (55)  9 (45) 
Clindamycin  3 (17.04)  20 (86.96) 14 (70)  6 (30) 
Tetracycline  6 (26.09)  17 (73.91) 17 (65)  3 (35) 
Gentamycin  16 (69.57)  7 (30.43) 17 (85)  3 (15) 
Trimethoprim/sulf
amethoxazole  
17 (73.91)  6 (26.09) 16 (80)  4 (20) 
Ciprofloxacin  18 (78.26) 0 (0) 5 (21.74) 18 (90) 1 (5.0) 1 (5.0) 
Levofloxacin  18 (78.26)  5 (21.74) 19 (95)  1 (5.0) 
Moxifloxacin  18 (78.26) 1  (4.35) 4 (17.39) 19 (95) 0 (0) 1 (5.0) 
Rifampin  22 (95.65) 0 (0) 1 (4.35) 14 (70) 5 (25) 1 (5.0) 
Vancomycin  23 (100)   20 (100)   
Quinupristin/dalfo
pristin 
21 (100)   22 (100)   
Linezolid  23 (100)   20 (100)   
Tigecycline 23 (100)   20 (100)   
 
 
 
Discussion 
 
 The methicillin-resistant in S. aureus strains 
are encoded by mobile genes with the mecA and 
femB gene was the most frequently. The incidence of 
MRSA varies from region to region. In our study, 
among 43 S. aureus strains have been analysed in 
BSI patients, 53.5% strains were identified as MRSA 
that was higher than study in Northern Vietnam (37%) 
[17]. Comparing with other countries, it was higher 
than the Philippines (38.1%), India (22.6%) [19] but 
lower than that of Korea (77.6%), Taiwan (65%), Hong 
Kong (56.8%), Sri Lanka (86.5%) [19].  
 Almost cases (22/23) with MRSA had mecA 
gene and the 100% resistance to penicillin was found 
that in line with the present study [20]. Our results 
about mecA gene have been shown that 
the mecA gene is responsible for resistance to 
methicillin [21] with the mechanisms have been 
proved [11] and 15% strains in MSSA group 
possessed this gene. Mohanasoundaram et al. 
showed similar findings with 100% MRSA possessed 
mecA gene, and only one MSSA strain had 
maintained this gene [22]. The 15% rate of MSSA 
positive for the mecA gene is quite high, and field 
literature reported a rate of 3% for MSSA positive for 
mecA [23]. The potential explanation regarding this 
high number is that the resistance gene transmitted in 
the hospital between bacteria. Thus, this finding in our 
study provides useful information to determine the 
prevalence of mecA gene in MSSA patients. In our 
study, femB gene was detected in almost S. aureus 
isolates, 82.6% in MRSA and 95% in the MSSA 
group, respectively. This result corroborated with 
Kobayashi et al. [24] but the differences between two 
studies that needed to highlight were the expression 
of femA gene showed very high (89.4%) [24] in 
Kobayashi’s study and lower rate in our research 
(48.8%). Further analysis of the expression of these 
genes in staphylococci will be needed. 
 MRSA in BSIs has been shown substantial 
increase in the 21 century [25]. As a result, its burden 
was growing not only in Europe [15], [26] but also 
worldwide [27]. Finding the appropriate therapy 
became crucial and glycopeptides had been used as 
an effective empirical antibiotic therapy for MRSA[28]. 
But in the time of antibiotics and resistance becoming 
popular, S. aureus also starts resistance to 
vancomycin that leading high financial burden and 
increased mortality [29], [30], [31]. The knowledge of 
antibiotic resistance profile is critical in clinical 
practice. In our study, some routine antibiotic agents 
used commonly in our area showed high resistance. 
The results of our study also showed that vancomycin, 
tigecycline, linezolid, quinupristin/dalfopristin emerged 
as choices for empiric therapy instead. Fan Zhang et 
al. showed similar findings with a high rate of 
resistance to penicillin (100%), erythromycin (73.3%) 
and clindamycin (57.3%) and the clear choice for 
treatment were vancomycin in these cases [20]. In our 
study, methicillin-resistant encoding genes showed 
high correlation with antibiotic resistance. Penicillin, 
erythromycin, clindamycin, and tetracycline showed 
resistant to MRSA but susceptibility to MSSA. The 
remarkable results in our study were that vancomycin, 
tigecycline, linezolid, quinupristin/dalfopristin were 
entirely susceptible to both groups. It guides to use 
antibiotics in case of suspecting bloodstream infection 
caused by S. aureus. 
 Limitation of study: The isolates of S. aureus 
strains included seem to be quite old (2012-2014), but 
it still plays an important role in the reflection of the 
current epidemiological situation. The isolates 
included were small (43 isolates) because we focused 
on only bloodstream infection patients and these 
results of our study were useful for this kind of patient. 
 As a conclusion, in S. aureus causing 
bloodstream infections, antibiotic resistance was 
higher in penicillin, erythromycin, and clindamycin. All 
strains were entirely susceptible to vancomycin, 
tigecycline, linezolid, quinupristin/dalfopristin.  
 
Ethical approval 
 
 This study is approved by the ethics 
committee of National Hospital of Tropical Diseases 
and Military Hospital 103.  
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Informed consent 
 
 The consent and commitment were signed by 
the patients in the study. 
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